Trending News
News

News
Deutsch Foundation-Sponsored Work Offers Multi-Pronged Attack on Major Medical Problem
Researchers create a microfluidic “lab on a chip” that uses light to monitor biofilm formation and biofilm response to drugs, detects growth and thickening of biofilms by monitoring translucency.

News
SSB and G-Con Manufacturing Announce Global Collaboration
Collaboration will support faster and more flexible facility construction and shortened time to market.

News
MGB Biopharma and Almac Collaborate on Contract Manufacturing Project
Almac to manufacture the production of the gram positive antibacterial compound MGB-BP3.

News
Pherecydes Pharma Secures DGA Funding
French defence procurement agency invests EUR 900,000 towards a Pherecydes Pharma managed EUR 1.2-million project.

News
PBL Awarded Pioneering US Patent on RNAi
The United States Patent and Trademark Office (USPTO) has issued out US Patent, with fundamental claims directed to methods of gene silencing in many organisms.

News
Courtagen Life Sciences Acquires Medicinal Genomics
Medicinal Genomics, as a wholly owned subsidiary of Courtagen, will apply next-generation sequencing technologies to better understand and elucidate the medical properties of Cannabis.

News
Researchers Use Sugar to Halt Esophageal Cancer in Its Track
The findings, reported in the journal Nature Medicine, have important implications for patients and may help to monitor their condition and prevent the development of cancer.

News
SpineSmith Adds Talented Scientist to Research and Development Team
The Celling Biosciences company, that designs, develops and markets innovative technologies in the field of regenerative medicine, is pleased to announce the addition of Dr. Matthew Murphy to its team of PhDs.

News
Leading Romanian Research Institution Expands Capabilities With Purchase of a NanoInk DPN 5000 System
The DPN 5000 System will be used for supramolecular structure fabrication, molecular recognition and self-assembling process applications.

News
Stellar Biotechnologies Announces Investor Relations Agreement
Stellar Biotechnologies, Inc. is pleased to announce that it has retained TheBiotechPanel, Inc. to provide the Company with investor relations services, for an initial period of six months.
Advertisement